Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study

The relevance of circulating tumor DNA (ctDNA) analysis as a liquid biopsy and minimal residual disease tool in the management of classical Hodgkin Lymphoma (cHL) patients was demonstrated in retrospective settings and remains to be confirmed in a prospective setting. We developed a targeted Next-G...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Vincent Camus, Mathieu Viennot, Justine Lequesne, Pierre-Julien Viailly, Elodie Bohers, Lucile Bessi, Bénédicte Marcq, Pascaline Etancelin, Sydney Dubois, Jean-Michel Picquenot, Elena-Liana Veresezan, Marie Cornic, Lucie Burel, Justine Loret, Stéphanie Becker, Pierre Decazes, Pascal Lenain, Stéphane Lepretre, Emilie Lemasle, Hélène Lanic, Anne-Lise Ménard, Nathalie Contentin, Hervé Tilly, Aspasia Stamatoullas, Fabrice Jardin
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Ferrata Storti Foundation 2020-02-01
Серія:	Haematologica
Онлайн доступ:	https://haematologica.org/article/view/9656
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study

Схожі ресурси